By Beth W. Orenstein | Follow @HeartDiseases Medically reviewed by Farrokh Sohrabi, MD Heart disease on the rise When it comes to health-related matters of the heart, the news is not so good — a number of heart diseases are on the rise.
Archives for October 2013
Did you know that nearly 20 percent of corporate crime is being committed by companies that make products for your health? Sad but true, no less than 19 pharmaceutical companies made AllBusiness.com’s Top 100 Corporate Criminals List for the 1990s, and the trend has continued if not increased into the 21st Century.
ProArgi-9+ and the Physicians Desk Reference For over 67 years, medical specialists across the world have turned to the Physicians Desk Reference (PDR) as the authoritative source of information on drugs and prescribed substances. Synergy is pleased to announce that ProArgi-9+ will be included in the 2014 edition of the PDR, providing a new opportunity […]
As we approach the season of candy canes and peppermints, it’s a perfect time to pay homage to the medicinal herb that gives these winter treats their flavor: peppermint.
Statin cholesterol-lowering drugs are among the most widely prescribed drugs on the market, bringing in $20 billion a year.1 They are a top profit-maker for the pharmaceutical industry, in part due to relentless and highly successful direct-to-consumer advertising campaigns.
Mild B-12 Deficiency May Speed Dementia Study finds that the vitamin shortage might affect more people than previously thought.